National Jewish Health-Main Campus — Denver, Colorado

National Jewish Health-Main Campus is a clinical research site located in Denver, Colorado, United States 80206.

Crixeo Clinical Trials Trust Score: 30/100 (FAILING). This profile has not yet been claimed by the site owner.

National Jewish Health-Main Campus has participated in 92 clinical trials with 61 currently active.

Therapeutic areas: Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Denver

Browse all research sites in Colorado · View every site in Denver

• Cancer Centers of Colorado at Saint Joseph Hospital
• Centura Health Porter Adventist Hospital
• University of Colorado Denver Health Sciences
• The Childrens Hospital
• Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
• University of Colorado Denver /ID# 233676
• University of Colorado Cancer Center
• Project Safe, University of Colorado
• National Jewish Health, University of Colorado Denver
• Regents of the University of Colorado
• University of Colorado Cancer Center at UC Health Sciences Center
• Denver Health and Hospitals

Sponsor Feasibility Report

Trust Score: 30/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for National Jewish Health-Main Campus?

National Jewish Health-Main Campus has a Crixeo Trust Score of 30/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has National Jewish Health-Main Campus conducted?

National Jewish Health-Main Campus has 92 clinical trials on record, with 61 currently active. Their work covers Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8.

Is National Jewish Health-Main Campus accredited by Crixeo Clinical Trials?

National Jewish Health-Main Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about National Jewish Health-Main Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.